熱門資訊> 正文
Wave Life Science股价上涨3.5亿美元
2025-12-10 14:53
- Wave Life Sciences (WVE) priced an upsized underwritten public offering of ~15.8M shares at a price to the public of $19.00 per ordinary share and pre-funded warrants to purchase up to 2.63M at $18.9999.
- Gross proceeds to Wave Life Sciences are to be ~$350M.
- The underwriters have a 30-day option to purchase up to an additional ~2.76M shares.
- The offering is expected to close on or about December 11, 2025.
More on Wave Life Sciences
- Wave Life Sciences Ltd. (WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity Transcript
- Wave Life Sciences: Being Realistic, There Is Still So Much To Prove
- Wave Life Sciences Ltd. (WVE) Q3 2025 Earnings Call Transcript
- Wave Life Sciences upgraded at RBC following data for obesity asset WVE-007
- Wave Life Sciences announces $250M public offering and pre-funded warrants
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
